![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Ripply3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of RIPPLY3 mRNA | CTD | PMID:22206623 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of RIPPLY3 mRNA | CTD | PMID:24140754 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ripply3 (Mus musculus) | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of RIPPLY3 exon and bis(4-hydroxyphenyl)sulfone affects the methylation of RIPPLY3 gene | CTD | PMID:31683443 and PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | Fenretinide results in increased expression of RIPPLY3 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Decitabine affects the expression of RIPPLY3 mRNA | CTD | PMID:23300844 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RIPPLY3 mRNA | CTD | PMID:30047161 | 7,12-dimethyltetraphene | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | 9 more ... | CTD | PMID:21527772 | actinomycin D | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Dactinomycin results in increased expression of RIPPLY3 mRNA | CTD | PMID:21527772 | aflatoxin B1 | affects expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of RIPPLY3 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of RIPPLY3 mRNA | CTD | PMID:21527772 and PMID:21632981 | all-trans-retinoic acid | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RIPPLY3 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of RIPPLY3 mRNA | CTD | PMID:20488242 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of RIPPLY3 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of RIPPLY3 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases methylation | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of RIPPLY3 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RIPPLY3 mRNA | CTD | PMID:22228805 and PMID:22610609 | benzo[b]fluoranthene | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of RIPPLY3 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of RIPPLY3 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of RIPPLY3 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPPLY3 gene | CTD | PMID:31601247 | carbon nanotube | decreases expression | ISO | Ripply3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RIPPLY3 gene] | CTD | PMID:28238834 | choline | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIPPLY3 gene | CTD | PMID:20938992 | chrysene | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA | CTD | PMID:27858113 | cisplatin | affects expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Cisplatin affects the expression of RIPPLY3 mRNA | CTD | PMID:23300844 | cisplatin | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RIPPLY3 mRNA | CTD | PMID:27392435 | copper atom | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RIPPLY3 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RIPPLY3 mRNA | CTD | PMID:20971185 | copper(II) sulfate | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of RIPPLY3 mRNA | CTD | PMID:19549813 | cyclophosphamide | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Cyclophosphamide results in increased expression of RIPPLY3 mRNA | CTD | PMID:21527772 | cyclosporin A | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of RIPPLY3 mRNA | CTD | PMID:20106945 | dioxygen | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RIPPLY3 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | etoposide | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Etoposide results in increased expression of RIPPLY3 mRNA | CTD | PMID:21527772 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of RIPPLY3 mRNA | CTD | PMID:30307764 | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of RIPPLY3 mRNA | CTD | PMID:31881178 | folic acid | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIPPLY3 gene | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of RIPPLY3 gene | CTD | PMID:31601247 | inulin | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RIPPLY3 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIPPLY3 gene | CTD | PMID:20938992 | mercury dibromide | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY3 mRNA | CTD | PMID:27188386 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of RIPPLY3 mRNA | CTD | PMID:30047161 | ozone | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RIPPLY3 mRNA | CTD | PMID:27106289 | p-chloromercuribenzoic acid | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of RIPPLY3 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY3 mRNA | CTD | PMID:27188386 | pentanal | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | pentanal results in increased expression of RIPPLY3 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RIPPLY3 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of RIPPLY3 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY3 mRNA | CTD | PMID:27188386 | potassium dichromate | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of RIPPLY3 mRNA | CTD | PMID:23608068 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of RIPPLY3 mRNA | CTD | PMID:30047161 | quercetin | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of RIPPLY3 mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of RIPPLY3 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | RIPPLY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of RIPPLY3 mRNA | CTD | PMID:34973136 | sodium arsenite | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RIPPLY3 mRNA | CTD | PMID:34032870 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of RIPPLY3 mRNA | CTD | PMID:30047161 | tetraphene | multiple interactions | ISO | Ripply3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RIPPLY3 mRNA | CTD | PMID:27858113 | titanium dioxide | decreases expression | ISO | Ripply3 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RIPPLY3 mRNA | CTD | PMID:23557971 | trichostatin A | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of RIPPLY3 mRNA | CTD | PMID:24935251 | urethane | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of RIPPLY3 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | Ripply3 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of RIPPLY3 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RIPPLY3 mRNA | CTD | PMID:25979313 | valproic acid | increases methylation | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of RIPPLY3 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of RIPPLY3 mRNA | CTD | PMID:23179753 and PMID:25192806 | valproic acid | increases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of RIPPLY3 mRNA | CTD | PMID:24383497 and PMID:24935251 | zoledronic acid | decreases expression | ISO | RIPPLY3 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of RIPPLY3 mRNA | CTD | PMID:24714768 | |